Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + Chemo in Post-Bevacizumab Breast Cancer
NCT00493636Phase 2Completed
- Sponsor
- Accelerated Community Oncology Research Network
- Start
- Jun 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by Accelerated Community Oncology Research Network. Started Jun 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00493636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493636.